NEW YORK--(BUSINESS WIRE)--May 5, 2006--Callisto Pharmaceuticals, Inc. (AMEX:KAL - News; FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, will present an overview of the Company’s innovative cancer-fighting drug development research and clinical programs at the upcoming the Rodman & Renshaw 3rd Annual Global Healthcare Conference, a leading annual biotechnology forum for global investors and financial professionals.
